Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics.

Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics.

Item
http://www.wikidata.org/entity/Q37746097
Intravitreal kinetics of hesperidin, hesperetin, and hesperidin G: effect of dose and physicochemical properties.Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor betaPharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.Intravitreal drug delivery in retinal disease: are we out of our depth?Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.Novel endogenous glycan therapy for retinal diseases: safety, in vitro stability, ocular pharmacokinetic modeling, and biodistribution.Synthesis and characterization of in situ forming anionic hydrogel as vitreous substitutes.Principles of pharmacology in the eye.Comparative Study of In Situ Loaded Antibody and PEG-Fab NIPAAM Gels.Estimation of Intra-vitreal Half-Lifes in the Rabbit Eye with Semi-mechanistic Equations.Short-term efficacy of intravitreal aflibercept for patients with treatment-naïve polypoidal choroidal vasculopathy.Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS.Effect of aflibercept in patients with age-related macular degeneration.
P2860

Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics.

Item
http://www.wikidata.org/entity/Q37746097
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intravitreal therapy for neova ...... in vitreous pharmacokinetics.
@en
Intravitreal therapy for neova ...... in vitreous pharmacokinetics.
@nl
type
label
Intravitreal therapy for neova ...... in vitreous pharmacokinetics.
@en
Intravitreal therapy for neova ...... in vitreous pharmacokinetics.
@nl
prefLabel
Intravitreal therapy for neova ...... in vitreous pharmacokinetics.
@en
Intravitreal therapy for neova ...... in vitreous pharmacokinetics.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Intravitreal therapy for neova ...... in vitreous pharmacokinetics.
@en
P2093
P304
P31
P356
10.1016/J.PRETEYERES.2010.04.003
P433
P478
P50
P577
P5875
P698